Literature DB >> 23085525

Peripheral nerve injury decreases the expression of metabolic glutamate receptor 7 in dorsal root ganglion neurons.

Jian-You Li1, Xiang Wang, Peng-Tian Ji, Xiong-Feng Li, Guo-Hua Guan, Xue-Sheng Jiang, Guo-Shun Zhou, Feng Hua, Nan Wang.   

Abstract

Group II and III metabolic glutamate receptors (mGluRs) are responsible for the glutamate-mediated postsynaptic excitation of neurons. Previous pharmacological evidences show that activation of mGluR7 could inhibit nociceptive reception. However, the distribution and expression patterns of mGluR7 after peripheral injury remain unclear. Herein we found that mGluR7 was expressed in the rat peptidergic dorsal root ganglion (DRG) neurons and large neurons, but rarely in isolectin B4 positive neurons. Sciatic nerve ligation experiment showed that mGluR7 was anterogradely transported from cell body to the peripheral site. Furthermore, after peripheral nerve injury, mGluR7 expression was down-regulated in both peptidergic and large DRG neurons. Our work suggests that mGluR7 might be involved in the regulation of pathological pain after peripheral nerve injury.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085525     DOI: 10.1016/j.neulet.2012.10.014

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Selective activation of metabotropic glutamate receptor 7 blocks paclitaxel-induced acute neuropathic pain and suppresses spinal glial reactivity in rats.

Authors:  Jiali Wang; Changyu Jiang; Xiyuan Ba; Shimin Yang; Jiaman Wu; Zelin Huang; Guangyi Jin; Yue Hao
Journal:  Psychopharmacology (Berl)       Date:  2020-10-22       Impact factor: 4.530

2.  Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat.

Authors:  Enza Palazzo; Ida Marabese; Livio Luongo; Serena Boccella; Giulia Bellini; Maria Elvira Giordano; Francesca Rossi; Mariantonietta Scafuro; Vito de Novellis; Sabatino Maione
Journal:  Mol Pain       Date:  2013-09-03       Impact factor: 3.395

3.  Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

Authors:  Asha R Kallianpur; Peilin Jia; Ronald J Ellis; Zhongming Zhao; Cinnamon Bloss; Wanqing Wen; Christina M Marra; Todd Hulgan; David M Simpson; Susan Morgello; Justin C McArthur; David B Clifford; Ann C Collier; Benjamin B Gelman; J Allen McCutchan; Donald Franklin; David C Samuels; Debralee Rosario; Emily Holzinger; Deborah G Murdock; Scott Letendre; Igor Grant
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

Review 4.  Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: etiological contribution to complex regional pain syndromes (Part II).

Authors:  Fuzhou Wang; George B Stefano; Richard M Kream
Journal:  Med Sci Monit       Date:  2014-07-12

Review 5.  The Glutamatergic System in Primary Somatosensory Neurons and Its Involvement in Sensory Input-Dependent Plasticity.

Authors:  Julia Fernández-Montoya; Carlos Avendaño; Pilar Negredo
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

6.  Evidence for glutamate as a neuroglial transmitter within sensory ganglia.

Authors:  Ling-Hsuan Kung; Kerui Gong; Mary Adedoyin; Johnson Ng; Aditi Bhargava; Peter T Ohara; Luc Jasmin
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

7.  Sensory Input-Dependent Changes in Glutamatergic Neurotransmission- Related Genes and Proteins in the Adult Rat Trigeminal Ganglion.

Authors:  Julia Fernández-Montoya; Izaskun Buendia; Yasmina B Martin; Javier Egea; Pilar Negredo; Carlos Avendaño
Journal:  Front Mol Neurosci       Date:  2016-11-28       Impact factor: 5.639

Review 8.  Inhibitory Gi/O-coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics.

Authors:  Yevgen Yudin; Tibor Rohacs
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.